CUPERTINO, Calif.--(BUSINESS WIRE)--NextBio (http://www.nextbio.com) today announced that it has entered into a major licensing agreement with Johnson & Johnson (NYSE:JNJ) for use of NextBio’s innovative life sciences search engine and collaboration platform. NextBio is being used by researchers and clinicians at Johnson & Johnson Pharmaceutical Research & Development, Tibotec Therapeutics and Centocor.
